Search
Filter Results
Displaying 541–550 of 727 for “Visions 2020”
-
Jun 6, 2022
Passionate Professional Outreach Volunteer Helping Newly Diagnosed
Jim has always been avid about giving back to others, even after he was diagnosed with retinitis pigmentosa. And in the last few years, he’s begun working with the Foundation to help eye care professionals in the Cincinnati and Northern Kentucky area provide vital resources for their patients with retinal diseases.
-
May 1, 2024
Foundation Fighting Blindness To Host Annual 2024 Gala Night for Sight
The May 9th gala will raise awareness and fund research leading to treatments and cures for blinding diseases.
-
Legacy & Visionary Circle Dinner
We are honored to invite you to a special presentation and dinner in recognition of your commitment to the Foundation’s Legacy and Visionary Circle programs.
-
Apr 19, 2024
SalioGen Developing Novel Gene Insertion Therapy for Stargardt Disease
The company’s innovative Gene Coding™ platform enables seamless insertion of DNA into selective genomic locations.
-
Feb 21, 2024
jCyte Announces Plans to Launch Phase 3 Clinical Trial of Cell Therapy for RP
Known as retinal progenitors, the company’s jCells® are designed to preserve photoreceptors in people with retinitis pigmentosa (RP) and other retinal diseases.
-
Feb 1, 2024
Ascidian to Launch Clinical Trial for Stargardt Disease RNA Editing Therapy
ACDN-01 is the only genetic medicine entering clinical development for Stargardt disease.
-
Oct 25, 2023
Foundation Fighting Blindness and Eone Announce Partnership
Together, the Foundation Fighting Blindness and Eone are launching a new limited-edition tactile timepiece watch, the ChangeMaker.
-
Sep 18, 2023
Ocugen Reports Updated Results for Clinical Trial of Modifier Gene Therapy
The company is also launching modifier gene therapy clinical trials for GA and Stargardt disease
-
Aug 28, 2023
Atsena Doses First Patient in XLRS Gene Therapy Clinical Trial
The AAV.SPR gene delivery system used in the trial is designed to more safely reach targeted retinal cells
-
Aug 4, 2023
Karen Petrou Appointed Foundation Chair Effective July 1, 2024, Upon the Retirement of David Brint
Special Foundation Announcement from Jason Menzo